BMY
56
3
NRG
69
12
PPG
61
-5
ZTS
56
-2
PGR
68
3
O
31
3
ADI
59
-2
PFE
30
-3
DOV
64
-5
KSS
39
6
RSG
59
2
AMG
41
-3
TGNA
48
-2
SWKS
38
-2
ETR
68
2
DHR
56
-4
APA
25
-3
TXN
50
-3
PPL
65
6
FAST
46
-3
BMY
56
3
NRG
69
12
PPG
61
-5
ZTS
56
-2
PGR
68
3
O
31
3
ADI
59
-2
PFE
30
-3
DOV
64
-5
KSS
39
6
RSG
59
2
AMG
41
-3
TGNA
48
-2
SWKS
38
-2
ETR
68
2
DHR
56
-4
APA
25
-3
TXN
50
-3
PPL
65
6
FAST
46
-3
Financhill
Back

Immuneering 10K Form

Buy
84

IMRX
Immuneering

Last Price:
3.19
Seasonality Move:
-30.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMRX News And Ratings

See the #1 stock for the next 7 days that we like better than IMRX

IMRX Financial Statistics

Sales & Book Value

Annual Sales: $316.95K
Cash Flow: $-11.56M
Price / Cash Flow: 0
Annual Sales: $2.24
Price / Book: 1.43

Profitability

EPS (TTM): -1.91000
Net Income (TTM): $-56.07M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Immuneering Earnings Forecast

Key Immuneering Financial Ratios

  • The Selling, General & Administrative Expenses for IMRX have been equal to 4,924.12% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Immuneering Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMRX
Website: immuneering.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMRX Technical Analysis vs Fundamental Analysis

Buy
84
Immuneering (IMRX) is a Buy

Is Immuneering a Buy or a Sell?

  • Immuneering stock is rated a Buy
    The current Immuneering [IMRX] share price is $3.19. The Score for IMRX is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.